The tariff classification of Theophylline Extended-Release Tablets from Germany and Mirabegron Extended-Release Tablets from India
Reasoning
The tariff classification of Theophylline Extended-Release Tablets from Germany and Mirabegron Extended-Release Tablets from India
Cite this ruling
CBP Ruling N337124 (3004909291): The tariff classification of Theophylline Extended-Release Tablets from Germany and Mirabegron Extended-Release Tablets from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Iron Sucrose Injection USP in dosage form, from India
The tariff classification of Heparin Sodium for Injection in dosage form, from China
The tariff classification of Hydroxychloroquine Sulfate Tablets in dosage form, from India
The tariff classification of Dapsone Gel 5% and Dapsone Gel 7.5% in dosage form, from Canada
The tariff classification of Indomethacin Suppositories in dosage form, from India